We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Using Bayesian modeling in frequentist adaptive enrichment designs.
- Authors
Simon, Noah; Simon, Richard
- Abstract
Our increased understanding of the mechanistic heterogeneity of diseases has pushed the development of targeted therapeutics. We do not expect all patients with a given disease to benefit from a targeted drug; only those in the target population. That is, those with sufficient dysregulation in the biomolecular pathway targeted by treatment. However, due to complexity of the pathway, and/or technical issues with our characterizing assay, it is often hard to characterize the target population until well into large-scale clinical trials. This has stimulated the development of adaptive enrichment trials; clinical trials in which the target population is adaptively learned; and enrollment criteria are adaptively updated to reflect this growing understanding. This paper proposes a framework for group-sequential adaptive enrichment trials. Building on the work of Simon & Simon (2013). Adaptive enrichment designs for clinical trials. Biostatistics 14(4), 613-625), it includes a frequentist hypothesis test at the end of the trial. However, it uses Bayesian methods to optimize the decisions required during the trial (regarding how to restrict enrollment) and Bayesian methods to estimate effect size, and characterize the target population at the end of the trial. This joint frequentist/Bayesian design combines the power of Bayesian methods for decision making with the use of a formal hypothesis test at the end of the trial to preserve the studywise probability of a type I error.
- Subjects
BAYESIAN analysis; FREQUENTIST statistics; TARGETED drug delivery; BIOMOLECULE analysis; MEDICAL decision making; CLINICAL trials; EXPERIMENTAL design; PROBABILITY theory; RESEARCH funding; STATISTICAL models
- Publication
Biostatistics, 2018, Vol 19, Issue 1, p27
- ISSN
1465-4644
- Publication type
journal article
- DOI
10.1093/biostatistics/kxw054